Join
Live feed
·
PRReleasevia Quantisnow
Takeda Pharmaceutical Company Limited logo

FRUZAQLA(TM) (fruquintinib capsules) now reimbursed in Ontario to treat metastatic colorectal cancer (mCRC)

ByQuantisnow·Wall Street's wire, on your screen.
TAK· Takeda Pharmaceutical Company Limited
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TAK (Takeda Pharmaceutical Company Limited) and more on Quantisnow.